development companies with lots of cash and high cash to mkt cap ratios. CLDX could have done a merger with most of them but chose CuraGen. There has to be some good reason which has yet to come out, notwithstanding very substandard PR by CLDX.
You have a 'wide and loose' head and shoulders pattern with high volume after the nice advance from 4.85. That is why I sold. It could retest the rising bottoms trendline around $5 by the end of this month.
Exactly! Why can't management articulate to investors and FUTURE investors their strategic plan and benefits of the merger? That's all I'm asking for here. They need to be clear and new investors will come in.